Search Results 61-70 of 15334 for TNF
... Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy Scottsdale/Phoenix, AZ. A Phase 2 Multicenter, Randomized, Double-Blind Placebo ...
"It also appears to be efficacious in both the anti-TNF-exposed and anti-TNF-naive populations. So this will be a welcome addition to our armamentarium of ...
Han's studies. Impact of pro-inflammatory cytokine, TNF on ASM Ca2+ sensitivity and contractility. Dr. Han tests the hypothesis that TNF alters Ca2+ sensitivity ...
Cancer. Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye. Robert Nellis. November 13, 2014. First · Previous ... 324 · 325 · 326 ...
Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye. Robert Nellis. November 13, 2014. Cancer. Mayo Clinic Researchers Identify First ...
"For the last 25 years, tumor necrosis factor has been an important therapeutic target to treat autoimmune disease and tissue inflammation," says Mayo Clinic ...
Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye. Robert Nellis. November 13, 2014. Cancer.
New medications. The immunology of IBD is very complex, and drug targeting is complex. Within the United States, four anti-TNF agents are currently approved for ...
Interleukin-17 (IL-17) inhibitors include secukinumab (Cosentyx) and ixekizumab (Taltz). Tumor necrosis factor (TNF) inhibitors include etanercept (Enbrel), ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.